巴曲酶注射液治疗全聋型突发性聋的临床效果

摘要
图/表
参考文献(19)
相关文章 (15)

全文: PDF (0 KB) HTML (37 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨巴曲酶注射液治疗全聋型突发性聋的临床效果。方法选取2015年1月～2019年10月我院收治的80例全聋型突发性聋患者作为研究对象，按照随机数字表法将其分为观察组和对照组，每组各40例。对照组患者采用用注射用甲泼尼龙琥珀酸钠静脉注射、银杏叶提取物注射液静脉滴注等常规治疗方案，观察组患者在对照组的基础上加用巴曲酶注射液治疗。治疗前后进行纯音听阈测试，比较两组患者的疗效，并分析听力变化情况。结果观察组患者的显效率为55.00%，总有效率为72.50%，对照组患者的显效率为30.00%，总有效率为67.50%。观察组患者的显效率高于对照组，差异有统计学意义（P＜0.05）；两组患者的治疗总有效率比较，差异无统计学意义（P＞0.05）；治疗后，观察组患者的低频区平均听阈和中频区平均听阈低于对照组，差异有统计学意义（P＜0.05）；两组患者的高频区平均听阈比较，差异无统计学意义（P>0.05）。结论巴曲酶注射液治疗全聋型突发性聋有效，可以进一步改善患者的听力，对于中、低频听力的提高效果肯定，对高频听力的提高无明显作用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	冯玮

关键词 ：巴曲酶注射液, 全聋型, 突发性聋, 临床效果

Abstract：Objective To explore the clinical effect of Batroxobin Injection in the treatment of total deafness type sudden deafness.Methods A total of 80 patients with total deafness type sudden deafness who were hospitalized from January 2015 to October 2019 were selected as subjects and divided into the observation group and the control group according to the random number table method, with 40 cases in each group.Patients in the control group were treated by intravenous injection of Sodium Methylprednisolone Succinate and intravenous infusion of Extract of Ginkgo Biloba Injection.Patients in the observation group was treated by Batroxobin Injection on the basis of the control group.Pure tone audiometry was performed before and after treatment to compare the curative effect of the two groups and analyze the changes of hearing.Results The apparent efficiency of the observation group was 55.00%, the total effective rate was 72.50%.In the control group, the apparent efficiency was 30.00% and the total effective rate was 67.50%.The apparent efficiency in the observation group was higher than that of the control group, the difference was statistically significant (P＜0.05).Comparison of the total effective rate between the two groups showed no statistically significant difference (P＞0.05).After treatment, the average hearing threshold in the low-frequency and middle-frequency regions of the observation group were lower than those of the control group, with statistically significant differences (P＜0.05).There was no statistically significant difference in the average hearing threshold between the two groups in the high-frequency region (P＞0.05).Conclusion Batroxobin Injection was proved effective in the treatment of total deafness type sudden deafness, which could improve the hearing of patients in further.It has positive effect on the improvement of middle and low frequency hearing, but has no effect on the improvement of high frequency hearing.

Key words： Batroxobin Injection Total deafness type Sudden deafness Clinical effect

引用本文:

冯玮. 巴曲酶注射液治疗全聋型突发性聋的临床效果[J]. 中国当代医药, 2020, 27(23): 129-132.
FENG Wei. Clinical effect of Batroxobin Injection in the treatment of total deafness type sudden deafness. 中国当代医药, 2020, 27(23): 129-132.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2020/V27/I23/129

[1]	中华耳鼻咽喉头颈外科杂志编辑委员会，中华医学会耳鼻咽喉头颈外科学分会.突发性聋诊断和治疗指南（2015）[J].中华耳鼻咽喉头颈外科杂志，2015，50（6）：443-447.
[2]	袁进，徐舒舒，张肖林，等.突发性聋全聋型患者预后与实验室指标的相关性研究[J].临床耳鼻咽喉头颈外科杂志，2019，33（5）：421-424.
[3]	Lominadze D，Dean WL，Tyagi SC，et al.Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease[J].Acta Physiologica，2010，198（1）：1-13.
[4]	Suckfüll Markus，Wimmer Christoph，Reichel Oliver，et al.Hyperfibrinogenemia as a Risk Factor for Sudden Hearing Loss[J].Otol Neurotol，2002，23（3）：309.
[6]	吴继春，刘业海，黄新生，等.治疗前听力图形状与突发性聋预后关系分析[J].中华耳科学杂志，2011，9（1）：34-37.
[10]	刘苏辐，李健东，汪学勇，等.东菱迪芙治疗难治性中重度突发性聋疗效观察[J].中华耳科学杂志，2014，12（1）：103-105.
[11]	王向阳，石丽亚，徐珀.东菱迪芙治疗突发性耳聋的临床疗效观察[J].中华耳科学杂志，2004，2（2）：133-134.
[14]	周波，杨皖菁，张宇，等.巴曲酶联合舒血宁治疗平坦型突发性聋的疗效及血流变学分析[J].医学综述，2014，20（3）：572-574.
[5]	Kawakami M，Makimoto K，Yamamoto H，et al.The effect of batroxobin on cochlear blood flow[J].Acta Oto-Laryngologica，1992，112（6）：991-997.
[7]	Li Y.Interventions in the management of blood viscosity for idiopathic sudden sensorineural hearing loss：A meta-analysis[J].J Health Res Rev，2017，4（2）：50．
[8]	Michel O.The revised version of the german guidelines "sudden idiopathic sensorineural hearing loss"[J].Laryngo-Rhino-Otologie，2011，90（5）：290-293.
[9]	Kim C，Sohn JH，Jang MU，et al.Ischemia as a potential etiologic factor in idiopathic unilateral sudden sensorineural hear ing loss：Analysis of posterior circulation arteries[J].Hear Res，2016，331：144-151.
[12]	Ihler F，Strieth S，Pieri N，et al.Acute hyperfibrinogenemia impairs cochlear blood flow and hearing function in guinea pigs in vivo[J].Int J Audiol，2012，51（3）：210-215.
[13]	Weiss BG，Bertlich M，Bettag SA，et al.Drug-induced Defibrinogenation as New Treatment Approach of Acute Hearing Loss in an Animal Model for Inner Ear Vascular Impairment[J].Otol Neurotol，2017，38（5）：648-654.
[15]	董和霞，王晓辉.纤溶酶治疗全聋型或接近全聋型突发性聋的疗效观察[J].中华耳科学杂志，2011，9（3）：300.
[16]	Chen GH，Zhang R，Wang YG，et al.Multi-center study of clinical treatment on the flat type of sudden hearing loss[J].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi，2013，48（5）：374-378.
[17]	郑虹，戴晴晴，周莲，等.全聋型突发性聋药物治疗的多中心研究[J].中华耳鼻咽喉头颈外科杂志，2013，48（5）：379-384.
[18]	张国荣，李霞，范秀芳.新生儿低纤维蛋白原血症的相关因素分析[J].中国优生与遗传杂志，2006，14（7）：87-92.
[19]	吴旋，陈垲钿，刘敏，等.磁共振薄层及特殊成像技术在突发性聋病因诊断中的价值[J].中山大学学报（医学科学版），2016，37（6）：912-918.